TMCI · Treace Medical Concepts, Inc.
$4.79
+0.28 (+6.21%)
At close · Aug 14
Market Cap
$311.52M
Shares
65.03M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-03-17 | SEAN SCANLAN | Officer | 50,000 | 2025-03-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-06-14 | TIMBIE THOMAS E | Director | 24,266 | 2023-06-14 | ETRADE FINANCIAL CORPORATION |
| 2023-05-01 | TREACE JAMES T | Director | 10,000 | 2023-05-01 | Merrill Lynch |
Showing 1–3 of 3 filings